Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 11.12M P/E - EPS this Y 20.40% Ern Qtrly Grth -
Income -31.75M Forward P/E -0.44 EPS next Y -3.30% 50D Avg Chg -26.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -43.00%
Dividend N/A Price/Book 0.92 EPS next 5Y - 52W High Chg -77.00%
Recommedations 1.50 Quick Ratio 2.14 Shares Outstanding 25.21M 52W Low Chg 7.00%
Insider Own 0.24% ROA -54.28% Shares Float 21.51M Beta -2.88
Inst Own 22.43% ROE -289.26% Shares Shorted/Prior 1.92M/2.11M Price 0.96
Gross Margin - Profit Margin - Avg. Volume 73,264 Target Price 18.60
Oper. Margin - Earnings Date Nov 6 Volume 31,367 Change 4.35%
About Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.

Tempest Therapeutics, Inc. News
11/12/24 Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12/24 Tempest Receives FDA Study May Proceed for Pivotal Phase 3 Trial of Amezalpat Combination Therapy for the Treatment of First-Line Hepatocellular Carcinoma
10/10/24 Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial
10/10/24 Tempest Extends Limited Duration Stockholder Rights Plan
09/20/24 Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/18/24 Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs
09/05/24 Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference
08/23/24 Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
07:00 AM Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance
08/15/24 Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma
08/08/24 Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update
06/20/24 Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
06/18/24 Tempest to Report New Data from Global Randomized Combination Study of Amezalpat (TPST-1120) in First-Line Hepatocellular Carcinoma
07:00 AM Tempest to Participate in Upcoming Investor Conferences
05/09/24 Tempest Reports First Quarter 2024 Financial Results and Provides Business Update
04/09/24 Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting
04/04/24 Tempest Announces Publication of Positive Data from Phase 1 Trial of TPST-1120 in Patients with Advanced Solid Tumors in Journal of Cancer Research Communications
03/19/24 Tempest Reports Year End 2023 Financial Results and Provides Business Update
03/12/24 Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
03/05/24 Tempest Announces Upcoming Presentation of Preclinical Data for TPST-1120 in Renal Cell Carcinoma at the AACR Annual Meeting
TPST Chatroom

User Image Bazzzigar Posted - 59 minutes from now

$TPST R/S or delisting?

User Image TAKERS1 Posted - 58 minutes from now

$TPST Another private placement on CDTX. While we are debating a R/S here…100m is peanut for VC

User Image Leon_32 Posted - 57 minutes from now

$TPST I would have stayed here if the board and management hadn't acted so stupidly and sell‘s 17 million shares, with a free float of only 25 million shares (70% dilution), were simply sold via ATM for just over $1 to private retailer and at the same time they claim they are worth $25 (poison pill). That is a scam and I always get annoyed that I fell for it. What I don't understand at all here is that some people, let's say, vote and simply go against the RSS. Do you actually know what happens then? As a penny stock with an MCAP of under $50 million, TPST no longer meets the listing rules for the Nasdaq, refinancing is no longer possible, the company burns through $5-10 million every month, they have hired endless people with sallary beyond $180,000 (see linkedin), all biotechs that run on Biz are penny stocks with historical losses of over 90%, BIZ receives shares as compensation. You guys need to wake up.

User Image AngelW86 Posted - 47 minutes from now

$TPST come on!!! Let’s get above $1

User Image Harleybug Posted - 23 minutes ago

$TPST so much bullshit on this board with all these pumpers , most pumpers sold but there still pumping , RS is gonna happen 1-15 is my quess tht means for every 15 you own turns into 1 there gonna steal your shares they have no choice writing is on the wall !

User Image Ataifanboymentalhealthz Posted - 1 hour ago

@Foramen_canal @DLBEE $CGTX can use atm without sec filing immediately being done. They don’t report it until earnings good example would be $TPST

User Image selviApple Posted - 3 hours ago

$TPST

User Image Andi422 Posted - 4 hours ago

$TPST soon they will Talk about a RS 1:2 - 1:10 Once they do, Price will Drop & I enter Cheap again

User Image Tennis2012 Posted - 4 hours ago

$TPST

User Image ericaddyman Posted - 7 hours ago

$TPST 🐂

User Image Harleybug Posted - 9 hours ago

$TPST it’s a pig this pig had its day and Brady is just trying to hold on to his pay check !

User Image LoUber Posted - 9 hours ago

$TPST @lgb2 ...until it's not ; )

User Image lgb2 Posted - 9 hours ago

$TPST no matter what a pig is a pig, no matter how you dress it

User Image GreylockSec Posted - 13 hours ago

$TPST Getting ready to catapult 🚀

User Image DRMANHATTAN_ Posted - 13 hours ago

$TPST still on watch. Last year the greedy bastards brought it down to .23 cents before the 10X it. Off chance it ever gets there I’ll enter big. This will probably trade in this current range before it moves up or down dramatically.

User Image OKBoomer19 Posted - 13 hours ago

$AMD $ARRY $BE $TPST I know I'm off topic, but I gotta vent! Usually drink my coffee black, but once in a while...add a little vanilla ice cream as a treat. This time put some aside in a cup to melt so that the coffee heat lasted longer. Cup full when filled, half full when melted. What? Due diligence = anywhere from 20% - 50% air, depending on brand. So don't consider volume, consider weight when purchasing. https://brooklynbrainery.com/blog/the-secret-to-cheap-supermarket-ice-cream-lots-and-lots-of-air

User Image Lastcall Posted - 14 hours ago

$TPST I voted like the 2020 election 😂

User Image StockAuthority Posted - 14 hours ago

$TPST im here for the 1.05 gap fill. SOON.

User Image OA_Trades Posted - 15 hours ago

$TPST On a lower time frame for a more granular view. I see a potential Inverse Head and Shoulders here at the bottom of this wedge fueling confluence.

User Image OA_Trades Posted - 15 hours ago

$TPST Our bullish hammer on the daily ( not a pinbar, but a hammer ) suggests investors are eating up the lower priced shares. It’s not a coincidence that this hammer exists OUTSIDE of the falling wedge signaling buying liquidity on the bullish side of the wedge. Don’t mind my new chart I loaded. It contains Gann Fans so any other trendlines you see besides the wedge; ignore. In summary I expect AT LEAST a technical bounce back to resistance. Fun fact, shorts have stop losses here. If you buy at market and eat away at the sell wall they will be forced to liquidate and help initiate a little squeeze here.

User Image PRG2022 Posted - 15 hours ago

$TPST I see Greyshock blabbing about Private Placements but it seems pretty clear nobody is interested.

User Image GreylockSec Posted - 17 hours ago

$TPST Can someone please explain to STEPHEN BRADY that Private Placements are back in vogue again and they're attracting a lot of investor interest. $DRUG skyrockets 5,000% on their $35 million dollar placement. Today $FBRX is up 125% on their $53 million dollar deal...! Let's go BRADY and MASTSAS...Show us the money!!

User Image Lastcall Posted - 17 hours ago

$TPST NO VOTE NOOO

User Image StockAuthority Posted - 19 hours ago

$SNSE I told you Harleybug is basically a basher account for a fund that knows a stock is going to have a huge move and whenever I see that account bashing, I buy big. It works every time. Made 25% off bottom in bio $TPST when that account showed up. That fund seems to be big into bio right now, which is understandable. Notice how he showed up and we ramped 10% almost out of nowhere? THey know this stock is super undervalued with 1000% avg analyst target, and will now be using that account to bash in hopes of getting some cheap shares.

User Image Blackorpinto Posted - 20 hours ago

$TPST back to .81 pig

User Image jtbose Posted - 20 hours ago

$TPST This thing can't seem to hit $1. Glad it's green but c'mon, let's go!

User Image Harleybug Posted - 20 hours ago

$TPST closes today at .78

User Image Buythetopofthebottom Posted - 21 hours ago

$TPST can I get that 40 buck target already.

User Image Smesic Posted - 21 hours ago

$TPST back to $1 we go! 🔥🙏

User Image OA_Trades Posted - 21 hours ago

$TPST I expect there to be a breakout to the upside this week. Technical analysis tells me we are *technically* bullish - even though we have made lower lows in the recent past.

Analyst Ratings
HC Wainwright & Co. Buy Aug 15, 24
Piper Sandler Overweight Jun 21, 24
HC Wainwright & Co. Buy Jun 20, 24
HC Wainwright & Co. Buy May 13, 24
HC Wainwright & Co. Buy May 10, 24
HC Wainwright & Co. Buy Mar 20, 24
Scotiabank Sector Outperform Mar 14, 24
Scotiabank Sector Outperform Mar 13, 24
HC Wainwright & Co. Buy Mar 12, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Woiwode Thomas Director Director Apr 29 Buy 2.36 2,118,644 5,000,000 2,118,644 05/03/22
Dubensky Thomas W. President President Jan 07 Buy 4.78 2,000 9,560 113,343 01/11/22
Whiting Samuel Chief Medical Office.. Chief Medical Officer Jan 06 Buy 4.8048 1,700 8,168 1,901 01/10/22